Skip to main content
Michael Ross, MD, Obstetrics & Gynecology, Torrance, CA

MichaelGRossMD

Obstetrics & Gynecology Torrance, CA

Maternal & Fetal Medicine/High Risk

Distinguished Professor, Obstetrics & Gynecology, UCLA School of Medicine

Dr. Ross is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ross' full profile

Already have an account?

  • Office

    1000 W Carson St
    Torrance, CA 90502
    Phone+1 310-663-9768
    Fax+1 310-868-2600

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Maternal-Fetal Medicine, 1982 - 1984
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1979 - 1982
  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1978 - 1979
  • Harvard School of Public Health
    Harvard School of Public HealthMPH, Health Services Administration, 1974 - 1978
  • Harvard Medical School
    Harvard Medical SchoolClass of 1978
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyBS, Life Sciences, Phi Beta Kappa, 1970 - 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2026
  • FL State Medical License
    FL State Medical License 2011 - 2021
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Maternal-Fetal Medicine

Awards, Honors, & Recognition

  • Distinguished Professor of Obstetrics and Gynecology and Public Health UCLA
  • Super Doctor SuperDoctors.com
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Mechanisms Of Programmed Gestational HyperphagiaEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2012
  • DO Ionized Magnesium Levels Predict Clinical Effects Better THAN Total MagnesisNational Center For Research Resources2007–2008
  • Aquaporin Gene Expression In Human Fetal MembraneNational Center For Research Resources2004–2008
  • Fetal Swallowing: Central Dipsogenic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
  • The Comparison Of Placental And Umbilical Nucleated Red Blood Cell CountNational Center For Research Resources2005–2006
  • Osmoregulation In Postpartum Women And Newborn InfantsNational Center For Research Resources2004
  • Fetal Urine Production&Swallowing Rate: Correlation With Amniotic Fluid VolumeNational Center For Research Resources2004
  • Comparison Of Placental And Umbilical Nucleated RedNational Center For Research Resources2004
  • Fetal Membrane AQP Expression/Amniotic Fluid RegulationEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2004
  • Leptin &Neuropeptide-Y Alters Fetal Swallowing ActivityEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
  • Maternal Dehydration--Fetal/Amniotic Fluid HomeostasisNational Heart, Lung, And Blood Institute1999–2002
  • Fetal Swallowing--Central Dipsogenic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
  • Prevention &Treatment Of Human OligohydramniosNational Center For Research Resources1999–2001
  • Osmoregulation In Postpartum Women &Newborn InfantsNational Center For Research Resources1999–2001
  • Novel Estrogen Stimulated Material (Oxytocin Glycine) In Human PlasmaNational Center For Research Resources1999–2001
  • Maternal Ddavp For Treatment Of Oligohydramnios In Preterm PrematureNational Center For Research Resources1999–2001
  • Double Lumen, Uterine Catheter For AmnioinfusionNational Center For Research Resources1999–2001
  • Prevention And Treatment Of Human OligohydramniosEunice Kennedy Shriver National Institute Of Child Health &Human Development1999–2001
  • Novel Method For Amniotic Fluid CalculationNational Center For Research Resources1997–2001
  • Gentamicin/Clindamycin In Prevention Of Postpartum EndomyometritisNational Center For Research Resources1996–2001
  • Amnioinfusion For Failed Version Of Breech PresentationNational Center For Research Resources1996–2001
  • Aminoinfusion With Antibiotic On Incidence Of Maternal ChorioamnioniNational Center For Research Resources1996–2001
  • Maternal Ddavp For Treatment Of OligohydramniosNational Center For Research Resources1994–2001
  • Prevention And Treatment Of Human OligohydromniosNational Center For Research Resources2000
  • Prevention And Treatement Of Human OligohydramniosNational Center For Research Resources2000
  • Fetal Urine Production &Swallowing Rates--Correlation With Amniotic FluidNational Center For Research Resources1998–1999
  • Ddavp Induced Hyponatremia For Treatment Of OligohydramniosNational Center For Research Resources1998–1999
  • Maternal Dehydration--Fetal &Amniotic Fluid HomeostasisNational Heart, Lung, And Blood Institute1991–1998
  • Fetal Maturation In A Model SystemNational Heart, Lung, And Blood Institute1997
  • Amnioinfusion--The Amniotic Fluid Index On Variable DecelerationsNational Center For Research Resources1996–1997
  • Fetal Swallowing--Ontogeny And RegulationNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1997
  • Perinatal BiologyEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1997
  • Prevention And Treatment Of Human OligohydramniosNational Center For Research Resources1996
  • Maternal Ddavp For Treatment Of Oligohydramnios In Preterm RuptureNational Center For Research Resources1996
  • Fetal Maturation In A Model SystemNational Heart, Lung, And Blood Institute1994–1996
  • Intraamniotic Ddavp For Treatment Of PolyhydramniosNational Center For Research Resources1994–1996
  • New Strategies To Mature The Premature FetusEunice Kennedy Shriver National Institute Of Child Health &Human Development1994–1996
  • Corticosteroid And Thyroid Effects On Lung MaturationEunice Kennedy Shriver National Institute Of Child Health &Human Development1992–1996
  • Lung Phospholipid Appearance And StabilityEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1996
  • Developmental Lung Phospholipid MetabolismEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1996
  • Fetal Maturation In A Model SystemNational Heart, Lung, And Blood Institute1994
  • Urinary TXA2 And PGI2 In Pre-EclampsiaNational Center For Research Resources1990–1991
  • Corticosteroid And Thyroid Effects On Lung MaturationEunice Kennedy Shriver National Institute Of Child Health &Human Development1985–1991
  • Maternal Dehydration--Fetal &Amniotic Fluid HomeostasisNational Heart, Lung, And Blood Institute1989–1990
  • Lung Phospholipid Appearance And StabilityEunice Kennedy Shriver National Institute Of Child Health &Human Development1988–1990
  • Developmental Lung Phospholipid MetabolismEunice Kennedy Shriver National Institute Of Child Health &Human Development1985–1990
  • Evaluation Of External Uterine TocodynamometerNational Center For Research Resources1989
  • Amniotic Fluid Homeostasis In The Ovine ModelEunice Kennedy Shriver National Institute Of Child Health &Human Development1986–1988
  • Relation Of Plasma Volume Expansion To VasopressinNational Center For Research Resources1985–1987
  • Fetal Role In OligohydramiosNational Center For Research Resources1985–1987
  • Lung Phospholpid Appearance And StabilityEunice Kennedy Shriver National Institute Of Child Health &Human Development1985–1987
  • Pre-Eclampsia--Clinical And Hormonal Response To Antepartum Volume ExpansionNational Center For Research Resources1985–1986